Please use this identifier to cite or link to this item:
Title: Telehealth to improve asthma control in pregnancy: a randomized controlled trial
Austin Authors: Zairina, Elida;Abramson, Michael J;McDonald, Christine F ;Li, Jonathan;Dharmasiri, Thanuja;Stewart, Kay;Walker, Susan P;Paul, Eldho;George, Johnson
Affiliation: Department of Respiratory and Sleep Medicine, Austin Health, Heidelberg, Victoria, Australia
Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Australia
Department of Pharmacy Practice, Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia
Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia
Allergy, Immunology and Respiratory Medicine, The Alfred Hospital, Melbourne, Australia
Department of Electrical and Computer Systems Engineering, Faculty of Engineering, Monash University, Melbourne, Australia
Department of Maternal Fetal Medicine, Mercy Hospital for Women, Melbourne, Australia
Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Australia
Department of Clinical Haematology, The Alfred Hospital, Melbourne, Australia
Issue Date: Jul-2016 2016-03-31
Publication information: Respirology 2016; 21(5): 867-874
Abstract: BACKGROUND AND OBJECTIVE: Poorly controlled asthma during pregnancy is hazardous for both mother and foetus. Better asthma control may be achieved if patients are involved in regular self-monitoring of symptoms and self-management according to a written asthma action plan. Telehealth applications to optimize asthma management and outcomes in pregnant women have not yet been evaluated. This study evaluated the efficacy of a telehealth programme supported by a handheld respiratory device in improving asthma control during pregnancy. METHODS: Pregnant women with asthma (n = 72) from two antenatal clinics in Melbourne, Australia, were randomized to one of two groups: (i) intervention-involving a telehealth programme (management of asthma with supportive telehealth of respiratory function in pregnancy (MASTERY(©) )) supported by a handheld respiratory device and an Android smart phone application (Breathe-easy(©) ) and written asthma action plan or (ii) control-usual care. The primary outcome was change in asthma control at 3 and 6 months (prenatal). Secondary outcomes included changes in quality of life and lung function, and perinatal/neonatal outcomes. RESULTS: At baseline, participants' mean (± standard deviation) age was 31.4 ± 4.5 years and gestational age 16.7 ± 3.1 weeks. At 6 months, the MASTERY group had better asthma control (P = 0.02) and asthma-related quality of life (P = 0.002) compared with usual care. There were no significant differences between groups in lung function, unscheduled health-care visits, days off work/study, oral corticosteroid use, or perinatal outcomes. Differences between groups were not significant at 3 months. CONCLUSION: Telehealth interventions supporting self-management are feasible and could potentially improve asthma control and asthma-related quality of life during pregnancy.
DOI: 10.1111/resp.12773
PubMed URL:
Type: Journal Article
Subjects: Asthma control
Pregnant women
Quality of life
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Dec 7, 2022

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.